BDNF (Brain-Derived Neurotrophic Factor) is a protein critical for neuroplasticity and neuronal survival. During menopause, estrogen levels decline, and because estrogen can upregulate BDNF expression, a common myth is that menopause inevitably causes a drastic BDNF drop leading to cognitive decline. The facts are more nuanced. While some studies show an association between low estrogen and reduced BDNF, the effect sizes are modest and not uniform across all women. Moreover, BDNF is influenced by many factors—exercise, sleep, diet, and stress. Another myth is that supplements (e.g., curcumin, omega-3s) reliably boost BDNF. Evidence is mostly mechanistic or from animal studies; human trials show inconsistent results. A DNA test for BDNF polymorphisms (e.g., Val66Met) may offer insights into individual BDNF regulation, but its clinical relevance for menopause is limited. In summary, BDNF is an interesting biomarker but not a standalone predictor of cognitive health during menopause. Lifestyle interventions likely have the greatest impact.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-bee0f333823799f2fe874027